William Westlin

5.4k citations

65 papers · 3.0k indexed · 1 hit paper · h-index 24

Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 6
Cancer Research top 5%
- Protease and Inhibitor Mechanisms 4
Genetics top 2%
- Chronic Lymphocytic Leukemia Research 8
Immunology top 5%
Pathology and Forensic Medicine top 5%
Oncology
- Peptidase Inhibition and Analysis 10
Cellular and Molecular Neuroscience
- Neuropeptides and Animal Physiology 7
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 6
Molecular Biology
- Sphingolipid Metabolism and Signaling 5
- Angiogenesis and VEGF in Cancer 4

Co-authors: Michael A. Gimbrone Kevin Mullane Rosana Kapeller Geraldine Harriman H. James Harwood Rosemary Kraemer Jeremy R. Greenwood Sathesh Bhat
Cited by: Immunology and Allergy Cancer Research Genetics
Journals: Bioorganic & Medicinal Chemistry Letters (5 papers)Cancer Research (4 papers)Journal of Hepatology (4 papers)
Partner nations: United States Japan Austria

In The Last Decade

William Westlin

64 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by William Westlin

Since Specialization

Citations

This map shows the geographic impact of William Westlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Westlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Westlin more than expected).

Fields of papers citing papers by William Westlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Westlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Westlin. The network helps show where William Westlin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside William Westlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William Westlin Line = papers co-authored together William Westlin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis Journal of Clinical Investigation ·Eric Gracey,蒲田和芳,Melissa Lim,Zoya Qaiyum,Toyos F. de los,Liana Triantafyllia Konstantinidou,Brit. J. Ophth. v. Chiang-Hua Yu,Yuriy Baglaenko,泰郎松本,William Westlin,C. E. Masse,Mathias Müller,Birgit Strobl,Wenyan Miao,Robert D. Inman	2020	54
2	A novel Bruton’s tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity Leukemia ·Homare Eda,Loredana Santo,Diana Cirstea,Andrew J. Yee,José Gonçalves Ferreira,Neeharika Nemani,Yuko Mishima,Peter Waterman,Shirin Arastu‐Kapur,Erica N Evans,Juswinder Singh,Christopher J. Kirk,William Westlin,Noopur Raje	2014	37
3	Metabolites of PPI-2458, a Selective, Irreversible Inhibitor of Methionine Aminopeptidase-2: Structure Determination and In Vivo Activity Drug Metabolism and Disposition ·Christopher C. Arico-Muendel,Bruce Belanger,Dennis R. Benjamin,А.А. Сенцов,Mustafa Kurban,Jennifer L. DeLorey,Younes Tlemcani,Ulrike Gradhand,Héctor M. Targovnik,Susan E. Hill,Matthew Labenski,Barry A. Morgan,Gary O’Donovan,Kavirayani R. Prasad,Steven R. Skinner,راضیه فلسفیان,Charles D. Thompson,James Wakefield,William Westlin,Kerry White	2013	9
4	Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans Journal of Pharmacology and Experimental Therapeutics ·Erica N Evans,Richland Tester,TURKER MUSA,Russell Karp,Michael P. Sheets,Matthew Labenski,Steven R. Witowski,Heather Lounsbury,Prasoon Chaturvedi,Hormoz Mazdiyasni,Zhendong Zhu,Mariana Nacht,Martin I. Freed,Russell C. Petter,V V Grinshkun,Juswinder Singh,William Westlin	2013	171
5	Exploring amino acids derivatives as potent, selective, and direct agonists of sphingosine-1-phosphate receptor subtype-1 Bioorganic & Medicinal Chemistry Letters ·Ghotas Evindar,Hongfeng Deng,Sylvie G. Bernier,Younes Tlemcani,Trinn Christoph,Barry A. Morgan,William Westlin	2012	2
6	Clinical Development of AVL-292; A Potent, Selective Covalent Btk Inhibitor for the Treatment of B Cell Malignancies, Blood ·Erica N Evans,Richland Tester,TURKER MUSA,Prasoon Chaturvedi,Hormoz Mazdiyasni,Sabine Ponader,Bethany Tesar,Michael P. Sheets,Mariana Nacht,A.K. Hulina,Hatice Kübra Zenger İlik,Heather Lounsbury,Russell C. Petter,Jennifer R. Brown,Jan A. Burger,Juswinder Singh,William Westlin	2011	19
7	Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine Nature Chemical Biology ·Margit Hagel,Deqiang Niu,Thia St Martin,Michael P. Sheets,Lixin Qiao,Hugues Bernard,Russell Karp,Zhendong Zhu,Matthew Labenski,Prasoon Chaturvedi,Mariana Nacht,William Westlin,Russell C. Petter,Juswinder Singh	2010	77
8	Synthesis and evaluation of arylalkoxy- and biarylalkoxy-phenylamide and phenylimidazoles as potent and selective sphingosine-1-phosphate receptor subtype-1 agonists Bioorganic & Medicinal Chemistry Letters ·Ghotas Evindar,Alexander L. Satz,Sylvie G. Bernier,Malcolm J. Kavarana,Younes Tlemcani,Trinn Christoph,راضیه فلسفیان,夏溦,Amy Hutchings,Michael S. P. Kelley,Junaid Ansari,Ashis Saha,Gerhard Hannig,Barry A. Morgan,William Westlin	2009	6
9	An inhibitor of methionine aminopeptidase type-2, PPI-2458, ameliorates the pathophysiological disease processes of rheumatoid arthritis Inflammation Research ·Douglas Lazarus,Younes Tlemcani,Tamer Fawzy Ismail,Azizah Yusra Amaliyah Harahap,Matthew Labenski,James Wakefield,Russell Karp,Renato Marin López,Trinn Christoph,Jennifer Hoyt,Charles D. Thompson,Gerhard Hannig,William Westlin	2008	11
10	Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonists Bioorganic & Medicinal Chemistry Letters ·Ghotas Evindar,Sylvie G. Bernier,Malcolm J. Kavarana,Younes Tlemcani,Trinn Christoph,Michael S. P. Kelley,夏溦,Amy Hutchings,Junaid Ansari,Ashis Saha,Gerhard Hannig,Barry A. Morgan,William Westlin	2008	11
11	Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI‐2458 Arthritis & Rheumatism ·Gerhard Hannig,Sylvie G. Bernier,Jennifer Hoyt,Ayse Yayl,O.D. Fedorovsky,Russell Karp,Trinn Christoph,William Westlin	2007	20
12	Methionine aminopeptidases type I and type II are essential to control cell proliferation Journal of Cellular Biochemistry ·Sylvie G. Bernier,راضیه فلسفیان,Charles D. Thompson,William Westlin,Gerhard Hannig	2005	59
13	A methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis Proceedings of the National Academy of Sciences ·Sylvie G. Bernier,Douglas Lazarus,Dr Huynh,Ayse Yayl,Matthew Labenski,Charles D. Thompson,William Westlin,Gerhard Hannig	2004	84
14	Functional Overlap and Cooperativity Among αv and β1 Integrin Subfamilies During Skin Angiogenesis Journal of Investigative Dermatology ·Carole Perruzzi,Mary C. Whelan,Donald R. Senger,Antonin R. de Fougerolles,Victor Koteliansky,William Westlin	2003	34
15	Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticles Magnetic Resonance in Medicine ·Stasia A. Anderson,Randall K. Rader,William Westlin,María Coro Solans López,Dowdy Jackson,Gregory M. Lanza,Samuel A. Wickline,John J. Kotyk	2000	209
16	Characterization of spontaneous metastasis in an aggressive breast carcinoma model using flow cytometry Clinical & Experimental Metastasis ·CCeconi,Steven L. Settle,Jeffery L. Keene,William Westlin,G. Allen Nickols,David W. Griggs	1999	33
17	Activated Neutrophils Release Mediators That May Contribute to Myocardial Injury and Dysfunction Associated with Ischemia and Reperfusiona Annals of the New York Academy of Sciences ·Kevin Mullane,William Westlin,Rosemary Kraemer	1988	100
18	Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? PubMed ·William Westlin,I.H. Boos	1988	199
19	Glandular Kallikrein Levels in the Rat Anterior Pituitary during the Estrous Cycle and Pregnancy1 Biology of Reproduction ·C. Andrew Powers,William Westlin	1987	7
20	Myocardial Salvage Induced by REV-5901 Journal of Cardiovascular Pharmacology ·Kevin Mullane,Mary Ann Hatala,Rosemary Kraemer,William C. Sessa,William Westlin	1987	42

About William Westlin

William Westlin is a scholar working on Immunology and Allergy, Genetics and Oncology, having authored 65 papers that have together received 3.0k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (10 papers), Chronic Lymphocytic Leukemia Research (8 papers), Neuropeptides and Animal Physiology (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Cell Adhesion Molecules Research (6 papers), Sphingolipid Metabolism and Signaling (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Protease and Inhibitor Mechanisms (4 papers). The work is most often cited by research in Immunology and Allergy (346 citations), Cancer Research (555 citations) and Genetics (357 citations). William Westlin has collaborated with scholars based in United States, Japan and Austria. Frequent co-authors include Michael A. Gimbrone, Kevin Mullane, Rosana Kapeller, Geraldine Harriman, H. James Harwood, Rosemary Kraemer, Jeremy R. Greenwood, Sathesh Bhat, Matthew Labenski and Gerhard Hannig. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Cancer Research, Journal of Hepatology, Blood and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact